{"id":20863,"date":"2023-05-23T12:01:01","date_gmt":"2023-05-23T10:01:01","guid":{"rendered":"https:\/\/lombardialifesciences.it\/transcan-2022-pubblicati-i-progetti-vincitori-per-la-lotta-contro-il-cancro\/"},"modified":"2023-10-17T09:36:24","modified_gmt":"2023-10-17T07:36:24","slug":"transcan-2022-pubblicati-i-progetti-vincitori-per-la-lotta-contro-il-cancro","status":"publish","type":"post","link":"https:\/\/lombardialifesciences.it\/en\/transcan-2022-pubblicati-i-progetti-vincitori-per-la-lotta-contro-il-cancro\/","title":{"rendered":"TRANSCAN 2022: ecco i progetti vincitori per la lotta contro il cancro"},"content":{"rendered":"

Sono stati pubblicati i risultati della Joint Transnational Call (JTC) 2022.<\/p>\n

14 i consorzi selezionati che riceveranno un finanziamento complessivo pari a \u20ac15,1 milioni per sviluppare nuovi approcci traslazionali affrontando le sfide dei tumori difficili da trattare.<\/p>\n

I progetti si occuperanno del rilevamento precoce dei tumori attraverso\u00a0strumenti innovativi,\u00a0implementando\u00a0l’efficacia di rilevamento, diagnosi, prognosi e trattamento dei tumori, attraverso\u00a0collaborazioni multidisciplinari e multiprofessionali.<\/p>\n

Di seguito i progetti selezionati. Evidenziati in grassetto quelli che coinvolgono ricercatori di enti soci del Cluster.<\/p>\n

    \n
  1. ANGELA \u2013 Early detection of esophageal squamous cell carcinoma with the Cytosponge coupled with molecular biomarkers and machine learning<\/li>\n
  2. BileCanMet \u2013<\/strong> Precision medicine in cholangiocarcinoma: accurate tools for early detection and identification of PRMT5 as a novel pharmacological target<\/li>\n
  3. CAR4PDAC \u2013 <\/strong>Hijacking stroma antigens for CAR-T cell immunotherapy of PDAC<\/li>\n
  4. iCC-Strat<\/strong> \u2013 Risk stratification and subtyping of intrahepatic cholangiocarcinoma for early detection of recurrence and response to immuno-therapy<\/li>\n
  5. IdeaTMEHCC \u2013 Identification of therapeutic targets using HCC DErived organoid Augmented with TME components.<\/strong><\/li>\n
  6. MATTO-GBM \u2013 Multimodality Artificial intelligence open-source Tools for Radiation Treatment Optimization in patients with Glioblastoma<\/li>\n
  7. NK-4-GBM \u2013 Metabolically optimised NK cell therapies for Glioblastoma<\/li>\n
  8. PaCaNano \u2013 Development of a pancreatic cancer drug-nanocarrier system selectively targeting tumour cells and tumour stroma to overcome treatment failure<\/li>\n
  9. PANC-P53 \u2013 Innovative peptide- and RNA-based strategies to modulate p53 for pancreatic cancer therapy<\/li>\n
  10. PLASTIG \u2013 Tackling tumor heterogeneity and PLASTIcity as resistance mechanisms in Glioblastoma<\/li>\n
  11. PRECEDENCE \u2013 Genotype matched therapies in intrahepatic cholangiocarcinoma: a multi-pronged strategy for improving efficacy and combating resistance.<\/li>\n
  12. ReachGLIO<\/strong> \u2013 Reaching the heterogeneous vascular landscape of glioblastoma with multifunctional nanomedicines.<\/li>\n
  13. SIMMBAP \u2013 Systemic immunological determinants of tumor evolution and therapy response in BRCA-mutated pancreatic cancer<\/li>\n
  14. T-Plex EAC<\/strong> \u2013 T-Plex-Capture: Isolation of neoantigen-specific CD8+ T cell receptors for patient-specific immunotherapy in esophageal adenocarcinoma (EAC)<\/li>\n<\/ol>\n

    Maggiori dettagli qui<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"

    Sono stati pubblicati i risultati della Joint Transnational Call (JTC) 2022. 14 i consorzi seleziona…<\/p>\n","protected":false},"author":1,"featured_media":20911,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"inline_featured_image":false,"footnotes":""},"categories":[44],"tags":[234,86,449,479],"class_list":["post-20863","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","tag-cancro","tag-humanitas","tag-ospedale-san-raffaele","tag-transcan"],"acf":[],"_links":{"self":[{"href":"https:\/\/lombardialifesciences.it\/en\/wp-json\/wp\/v2\/posts\/20863","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lombardialifesciences.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lombardialifesciences.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lombardialifesciences.it\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/lombardialifesciences.it\/en\/wp-json\/wp\/v2\/comments?post=20863"}],"version-history":[{"count":1,"href":"https:\/\/lombardialifesciences.it\/en\/wp-json\/wp\/v2\/posts\/20863\/revisions"}],"predecessor-version":[{"id":20913,"href":"https:\/\/lombardialifesciences.it\/en\/wp-json\/wp\/v2\/posts\/20863\/revisions\/20913"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/lombardialifesciences.it\/en\/wp-json\/wp\/v2\/media\/20911"}],"wp:attachment":[{"href":"https:\/\/lombardialifesciences.it\/en\/wp-json\/wp\/v2\/media?parent=20863"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lombardialifesciences.it\/en\/wp-json\/wp\/v2\/categories?post=20863"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lombardialifesciences.it\/en\/wp-json\/wp\/v2\/tags?post=20863"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}